Skip to main content
Clinical Trials/ACTRN12617000400369
ACTRN12617000400369
Recruiting
未知

Effect of Progressive Resistance Training on insulin resistance and depression in adults with Metabolic Syndrome and Major Depressive Disorder.

Dr Yorgi Mavros0 sites44 target enrollmentMarch 17, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Yorgi Mavros
Enrollment
44
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 17, 2017
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Yorgi Mavros

Eligibility Criteria

Inclusion Criteria

  • 1\. Major Depressive Disorder according to DSM 5 criteria,
  • \*If not receiving any treatment; PHQ\-9 of 10 or higher (moderate depression)
  • \*If receiving treatment, PHQ\-9 of 5 or higher (mild depression)
  • 2\. Metabolic syndrome according to IDF criteria
  • \*Central obesity (Waist circumference Men; greater than or equal to 94 cm men. Women; greater than or equal to 80 cm) and any 2 of the following:
  • \*Raised triglycerides (150 mg/dL (1\.7 mmol/L) or higher, or specific treatment for this lipid abnormality)
  • \*Low HDL cholesterol (Less than 40 mg/dL (1\.03 mmol/L) in men and less than 50 mg/dL (1\.29 mmol/L) in women or specific treatment for this lipid abnormality
  • \*Hypertension (systolic BP of 130 or higher, or diastolic BP of 85 mm Hg or higher, or treatment of previously diagnosed hypertension)
  • \*High fasting plasma glucose ((FPG) of 100 mg/dL (5\.6 mmol/L) or higher.
  • 3\. at least 40 years of age

Exclusion Criteria

  • Type 2 diabetes or use of oral hypoglycaemic medication or insulin
  • Suicide ideation
  • Illegal drug use
  • Alcohol dependence/abuse (3 or 4 on CAGE questionnaire)
  • Substance abuse disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials